Gossamer Bio

Gossamer Bio Shares Outstanding

The The number of shares of Gossamer Bio (GOSS) as of Nov 20, 2026 is 2.86 M. In the previous year, The number of shares was 2.86 M — a change of 0.00% (lower).

Shares Outstanding

2.86 M

YoY

0.00%

Last updated:

In 2025, Gossamer Bio had 2.86 M outstanding stocks, a 0.00% change from the 2.86 M stocks in the previous year.

The Gossamer Bio Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2023
2.86 M USD
Jan 1, 2024
2.86 M USD
Jan 1, 2025
2.86 M USD
Jan 1, 2026 (e)
2.83 USD
Jan 1, 2027 (e)
2.83 USD
Jan 1, 2028 (e)
2.83 USD
Jan 1, 2029 (e)
2.83 USD
Jan 1, 2030 (e)
2.83 USD
The Gossamer Bio Shares Outstanding history
YEARShares OutstandingYoY
est2.830.00%
est2.830.00%
est2.830.00%
est2.830.00%
est2.83-100.00%
2.86 M0.00%
2.86 M0.00%
2.86 M0.00%
2.86 M0.00%
2.86 M0.00%
2.86 M0.00%
2.86 M0.00%
2.86 M0.00%
2.86 M0.00%
2.86 M—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Gossamer Bio Number of shares

Gossamer Bio shares outstanding

The number of shares of Gossamer Bio was 2.83 M in 2025. This indicates how many shares Gossamer Bio is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2023
225.41 M Stocks
Jan 1, 2024
226.60 M Stocks
Jan 1, 2025
2.83 M Stocks
Jan 1, 2026 (e)
2.83 M Stocks
Jan 1, 2027 (e)
2.83 M Stocks
Jan 1, 2028 (e)
2.83 M Stocks
Jan 1, 2029 (e)
2.83 M Stocks
Jan 1, 2030 (e)
2.83 M Stocks

Gossamer Bio Stock analysis

What does Gossamer Bio do? The company Gossamer Bio Inc. was founded in 2015 by Faheem Hasnain and Sheila Gujrathi. The founders had previously worked at various biotechnology companies and now wanted to start their own company to develop innovative products in the field of immunology. Gossamer Bio is headquartered in San Diego, California and currently employs around 200 people. The company specializes in researching and developing therapeutics for a wide range of diseases, including respiratory diseases, cancer, immunological disorders, and infections. Gossamer Bio's business model is based on identifying promising new drug candidates and subsequently developing therapeutics that have the potential to improve patients' lives. Key pillars of the business model include partnerships with established companies and investors, as well as the rapid and efficient conduct of clinical trials. Gossamer Bio's portfolio includes various pipeline programs in different stages of development. An important focus is on the development of new drugs for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). A promising drug candidate in this area is GB001, an inhalation medication that aims to reduce inflammation in the airways. Another important program of Gossamer Bio is the development of therapeutics for the treatment of cancer. The company focuses on the development of drugs that target the body's immune system to specifically fight tumor cells. A promising drug candidate in this area is GB1275, an antibody that specifically targets a protein overexpressed by some types of cancer. In addition to these two focus areas, Gossamer Bio also has programs in the development of therapeutics for the treatment of immunological disorders such as inflammatory bowel disease and rheumatoid arthritis, as well as for the treatment of infections such as COVID-19. Overall, Gossamer Bio has a wide range of promising drug candidates that have the potential to revolutionize the field of immunology and disease management. The company is well positioned to make significant progress in the development of new therapeutics in the coming years and improve the lives of millions of patients worldwide. Gossamer Bio is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating Gossamer Bio's Shares Outstanding

Gossamer Bio's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Gossamer Bio’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Gossamer Bio’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Gossamer Bio’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Gossamer Bio stock

The number of shares of Gossamer Bio is 2.86 M in 2025.

The number of shares of Gossamer Bio changed from 2.86 M to 2.86 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares Gossamer Bio since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Gossamer Bio

All Key Metrics — Gossamer Bio